BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8861522)

  • 21. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.
    Tonon M; Piano S
    Med Clin North Am; 2023 May; 107(3):505-516. PubMed ID: 37001950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of cirrhotic ascites.
    Bashyam M; Lepore M; Harbord M
    Br J Hosp Med (Lond); 2015 Feb; 76(2):C28-32. PubMed ID: 25671487
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of ascites.
    Yu AS; Hu KQ
    Clin Liver Dis; 2001 May; 5(2):541-68, viii. PubMed ID: 11385975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
    Saab S; Nieto JM; Ly D; Runyon BA
    Cochrane Database Syst Rev; 2004; (3):CD004889. PubMed ID: 15266548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of complications of hepatic cirrhosis].
    Töx U; Goeser T
    Praxis (Bern 1994); 2005 May; 94(18):727-33. PubMed ID: 15938384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathophysiologic basis for the treatment of cirrhotic ascites.
    Wong F; Blendis L
    Clin Liver Dis; 2001 Aug; 5(3):819-32. PubMed ID: 11565142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The patient with refractory ascites.
    Gerbes AL
    Best Pract Res Clin Gastroenterol; 2007; 21(3):551-60. PubMed ID: 17544117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
    Shao J; Zhang L; Han GH; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):721-723. PubMed ID: 27938554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ascites and Chronic Liver Disease in Children.
    Bolia R; Srivastava A
    Indian J Pediatr; 2024 Mar; 91(3):270-279. PubMed ID: 37310583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy in hepatic ascites].
    Knoblauch M
    Praxis (Bern 1994); 1995 May; 84(19):561-3. PubMed ID: 7792465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascites: pathogenesis and therapeutic principles.
    Møller S; Henriksen JH; Bendtsen F
    Scand J Gastroenterol; 2009; 44(8):902-11. PubMed ID: 19479632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
    Rössle M; Gerbes AL
    Gut; 2010 Jul; 59(7):988-1000. PubMed ID: 20581246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
    N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.